Matches in Wikidata for { <http://www.wikidata.org/entity/Q64188330> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q64188330 description "clinical trial" @default.
- Q64188330 description "ensayu clínicu" @default.
- Q64188330 description "klinisch onderzoek" @default.
- Q64188330 description "клінічне випробування" @default.
- Q64188330 name "Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy." @default.
- Q64188330 type Item @default.
- Q64188330 label "Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy." @default.
- Q64188330 prefLabel "Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy." @default.
- Q64188330 P1132 Q64188330-AF7CDB09-FD6B-4788-A5A4-3089AB145093 @default.
- Q64188330 P1476 Q64188330-78A4C2D2-7AD3-446F-BFE5-DF96E942E374 @default.
- Q64188330 P17 Q64188330-29851E37-837F-4ADD-BD39-88172D10CE30 @default.
- Q64188330 P17 Q64188330-34DFCAAD-FC4A-46E9-920D-545727B5ED32 @default.
- Q64188330 P17 Q64188330-36505069-0DD2-460C-8AC6-2C0E558B543A @default.
- Q64188330 P17 Q64188330-39D21321-E129-4023-98E0-BBA8443B01FC @default.
- Q64188330 P17 Q64188330-40E19C35-71F6-4345-A351-DA460F72619A @default.
- Q64188330 P17 Q64188330-41AF63B8-716F-42E0-8E59-24624900998F @default.
- Q64188330 P17 Q64188330-6745518C-60BD-4817-B251-35123BBB93DD @default.
- Q64188330 P17 Q64188330-675FD5F3-5AF0-492D-ABA0-EE5B611ABD3C @default.
- Q64188330 P17 Q64188330-95F11F12-6B9A-444B-BDDC-4A3252E6E1C4 @default.
- Q64188330 P17 Q64188330-A4DE0B14-09D7-45DF-BFF9-482C01AA278A @default.
- Q64188330 P17 Q64188330-ADAF08C6-463C-49BB-A223-82C9AD882A11 @default.
- Q64188330 P17 Q64188330-B5F55DAE-7FB0-42EF-AB7E-275CFDE2F433 @default.
- Q64188330 P17 Q64188330-B6E2E556-99B9-4EDF-8A8D-242B44401C7D @default.
- Q64188330 P17 Q64188330-EA2F84D5-449C-4702-A330-A8F3CB4F3F76 @default.
- Q64188330 P17 Q64188330-FDDF6B3C-3FBE-472B-A5C7-4763D1DF24A3 @default.
- Q64188330 P2899 Q64188330-1E8B72A4-0C43-4833-BFB0-0D8936301ECE @default.
- Q64188330 P3098 Q64188330-75C9A483-B4B3-4C2C-818E-FDF866BF0D1E @default.
- Q64188330 P31 Q64188330-EA4ED13C-D3D8-4327-9592-253E2C521D6D @default.
- Q64188330 P580 Q64188330-DAD02411-2545-444B-869E-B1146CC11E2A @default.
- Q64188330 P582 Q64188330-EA1F43AB-012B-4EEF-92B8-8FAC7EFE9266 @default.
- Q64188330 P6099 Q64188330-A6E52630-2710-4BA0-BC85-9A501D43EF82 @default.
- Q64188330 P6153 Q64188330-16418951-8E1C-4A4B-8DCA-6075070191A6 @default.
- Q64188330 P6153 Q64188330-1D524B3C-353D-43FC-9403-FAD31DC9C384 @default.
- Q64188330 P6153 Q64188330-4C74A5DE-BE2D-48BC-9CA7-9E86EDFBC180 @default.
- Q64188330 P6153 Q64188330-556D3D0B-CBC3-4F62-A763-D2CC0AB079C1 @default.
- Q64188330 P6153 Q64188330-736CD6B6-610E-456B-A1C2-B3507E52CAFD @default.
- Q64188330 P6153 Q64188330-74A0C9BF-C1AC-465B-962E-2D147A9FF530 @default.
- Q64188330 P6153 Q64188330-76FD3207-78D3-444F-80E2-56F4A853137E @default.
- Q64188330 P6153 Q64188330-81495CF9-7305-4F18-82E2-22C59DED9D0B @default.
- Q64188330 P6153 Q64188330-8FAC2269-CEBB-4E14-A95B-15A03152EC61 @default.
- Q64188330 P6153 Q64188330-96DEDA08-2614-4DED-8A70-FA272A0157B7 @default.
- Q64188330 P6153 Q64188330-BC807E6E-7864-402F-BDBA-B9C0676CE82E @default.
- Q64188330 P6153 Q64188330-D52D7E1F-6B0C-4C62-B66F-CB3AA613BE2E @default.
- Q64188330 P8363 Q64188330-BEB2C0BB-64C5-47CF-A696-34B601381E7A @default.
- Q64188330 P1132 "+155" @default.
- Q64188330 P1476 "A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF THE SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB (PF-04383119) IN SUBJECTS WITH CANCER PAIN PREDOMINANTLY DUE TO BONE METASTASIS RECEIVING BACKGROUND OPIOID THERAPY" @default.
- Q64188330 P17 Q142 @default.
- Q64188330 P17 Q145 @default.
- Q64188330 P17 Q155 @default.
- Q64188330 P17 Q17 @default.
- Q64188330 P17 Q183 @default.
- Q64188330 P17 Q214 @default.
- Q64188330 P17 Q218 @default.
- Q64188330 P17 Q28 @default.
- Q64188330 P17 Q29 @default.
- Q64188330 P17 Q298 @default.
- Q64188330 P17 Q36 @default.
- Q64188330 P17 Q40 @default.
- Q64188330 P17 Q408 @default.
- Q64188330 P17 Q414 @default.
- Q64188330 P17 Q801 @default.
- Q64188330 P2899 "+18" @default.
- Q64188330 P3098 "NCT02609828" @default.
- Q64188330 P31 Q30612 @default.
- Q64188330 P580 "2015-10-28T00:00:00Z" @default.
- Q64188330 P582 "2020-03-22T00:00:00Z" @default.
- Q64188330 P6099 Q42824827 @default.
- Q64188330 P6153 Q11627631 @default.
- Q64188330 P6153 Q16576057 @default.
- Q64188330 P6153 Q170027 @default.
- Q64188330 P6153 Q17059128 @default.
- Q64188330 P6153 Q30270262 @default.
- Q64188330 P6153 Q319239 @default.
- Q64188330 P6153 Q39988 @default.
- Q64188330 P6153 Q50035373 @default.
- Q64188330 P6153 Q624119 @default.
- Q64188330 P6153 Q6954149 @default.
- Q64188330 P6153 Q74548271 @default.
- Q64188330 P6153 Q7488506 @default.
- Q64188330 P8363 Q78089383 @default.